Business Context and Reporting Period
Company: Trulieve Cannabis Corp.
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended December 31, 2025
Business Overview: Trulieve is a vertically integrated, multi-state cannabis operator headquartered in Tallahassee, Florida. As of December 31, 2025, the company operated 233 dispensaries and 15 cultivation/processing facilities across nine states (Florida, Arizona, Pennsylvania, West Virginia, Ohio, Georgia, Maryland, Connecticut, and Colorado). The company is the largest cannabis retailer in the United States by store count.
Key Financial Metrics
| Metric | 2025 (in millions) | 2024 (in millions) |
|---|---|---|
| Revenue | $1,181.2 | $1,186.5 |
| Gross Profit | $711.2 | $715.7 |
| Gross Margin | 60.2% | 60.3% |
| Operating Income | $143.5 | $97.8 |
| Net Loss (GAAP) | $(122.2) | $(160.6) |
| Adjusted EBITDA | $427.3 | $420.2 |
| Operating Cash Flow | $272.8 | $271.5 |
| Cash and Cash Equivalents | $255.5 | $238.8 |
| Total Debt (Private Placement + Notes) | $236.1 | $485.1 |
Material Changes vs. Prior Period
- Revenue Stability: Revenue decreased slightly by 0.4% ($5.3 million) to $1.18 billion. This was driven by a $18.4 million decrease in retail revenue due to price compression, partially offset by a $13.1 million increase in wholesale revenue from expanded partnerships in Maryland, Ohio, and Pennsylvania.
- Expense Reduction: Selling, General, and Administrative (SG&A) expenses decreased significantly by 12.8% ($65.2 million) to $445.2 million. The primary driver was a reduction in campaign and political contributions, which fell from $117.5 million in 2024 to $66.1 million in 2025.
- Debt Restructuring: The company completed a major debt refinancing. It fully redeemed $368.0 million of 8.0% Senior Secured Notes due 2026 (using ~$373.0 million cash) and fully repaid a $15.8 million mortgage note. Concurrently, it issued $140.0 million in new 10.5% Senior Secured Notes due 2030.
- Profitability: Operating income improved by 46.8% to $143.5 million, despite flat revenue, due to the significant reduction in SG&A expenses. Net loss narrowed by 23.9% to $122.2 million.
Guidance, Outlook, Risks, and Unusual Items
- Regulatory Developments: In December 2025, the company received conditional approval for a dispensing organization license in Texas. Additionally, the federal government announced an intention to fast-track the reclassification of marijuana to Schedule III under the Controlled Substances Act, which could reduce barriers to research and banking.
- Tax Contingency: The company faces a significant uncertain tax position liability of $668.4 million, primarily related to the IRS's interpretation of IRC Section 280E (which limits deductions for cannabis businesses). In September 2025, the IRS proposed additional penalties of approximately $38.1 million, which the company intends to contest vigorously.
- Capital Allocation: The company intends to use proceeds from new debt issuances for capital expenditures and general corporate purposes. It does not intend to pay dividends in the foreseeable future.
- Risks: Key risks include the continued illegality of cannabis under U.S. federal law, potential asset forfeiture, limited access to traditional banking, and intense competition in state markets. The company also highlighted risks related to inventory valuation and the potential for goodwill impairment.
Investor Verification Checklist
- Tax Liability Resolution: Verify the status of the $668.4 million uncertain tax position and the outcome of the IRS audit regarding the proposed $38.1 million penalty.
- Debt Service Capacity: Assess the impact of the new 10.5% interest rate on the $200 million aggregate principal of 2030 Notes (including the subsequent $60 million issuance in Jan 2026) on future cash flows.
- Texas Expansion: Monitor the final regulatory approval and operational timeline for the Texas dispensing license.
- Price Compression Trends: Evaluate whether the retail price compression observed in 2025 is a temporary market correction or a structural shift affecting long-term margins.
- Inventory Valuation: Review the assumptions used for net realizable value of the $242.3 million inventory balance, given the volatility of the cannabis market.